Key2Brain
- Biotech or pharma, therapeutic R&D
- Carve-out from a mid-size European specialty pharma – 8 years of development
- Next generation proprietary BBB-crossing technology platform
- Early pipeline of novel brain targeting therapies developed internally and in industry partnerships
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}